Meeting: 2017 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4501 Citation: J Clin Oncol 35, 2017 (suppl; abstr 4501) Authors: Dean F. Bajorin, Ronald De Wit, David J. Vaughn, et al. Background: Second-line chemotherapies (chemo) for advanced UC have limited clinical benefit (OS, 7-9 mo). Data from the...
Pro zobrazení tohoto obsahu je třeba být přihlášen.